Objective: To describe financial changes at Le Van Thinh Hospital from 2022 to 2024 in nominal and consumer price index (CPI)-adjusted real terms, and to identify selected financial governance signals.
Subjects and methods: A retrospective descriptive study used aggregated annual financial data for fiscal years 2022, 2023, and 2024. Absolute monetary values were converted to 2025 price levels using adjustment factors derived from annual average CPI. Analyses compared nominal and real growth and assessed eight composite financial indicators against orientation reference thresholds.
Results: In nominal terms, total revenue increased by 31.1%, total expenditure by 28.1%, and operating surplus by 27.1%. After CPI adjustment, the corresponding increases were 22.5%, 19.7%, and 18.7%. Drug costs increased by 68.0% in nominal terms and by 57.0% in real terms. In 2024, five indicators were within orientation reference ranges, while three required further monitoring: health insurance revenue concentration, direct medical cost-to-service revenue ratio, and operating surplus margin.
Conclusion: Presenting nominal and real-price financial data in parallel improves interpretation of hospital financial growth and reduces the risk of decisions based on inflation-inflated trends.